We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+0.09%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.86B
AUM Growth
+$83M
Cap. Flow
+$153M
Cap. Flow %
2.62%
Top 10 Hldgs %
16.53%
Holding
808
New
59
Increased
345
Reduced
246
Closed
48

Top Sells

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$28.5M
2
LUV icon
Southwest Airlines
LUV
+$19.5M
3
MCHP icon
Microchip Technology
MCHP
+$17.7M
4
MSFT icon
Microsoft
MSFT
+$16.8M
5
LOW icon
Lowe's Companies
LOW
+$16.2M

Sector Composition

Rank Sector Weight
1 Healthcare 23.16%
2 Technology 15.94%
3 Financials 14.63%
4 Consumer Discretionary 10.42%
5 Communication Services 8.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RVTY icon
376
Revvity
RVTY
$12.1B
$3.08M 0.05%
40,670
-43,791
-52% -$3.38M
STZ icon
377
Constellation Brands
STZ
$22.2B
$3.06M 0.05%
13,435
+832
+7% +$183K
HOG icon
378
Harley-Davidson
HOG
$2.61B
$3.04M 0.05%
70,870
-23,796
-25% -$1.14M
PXD
379
DELISTED
Pioneer Natural Resource Co.
PXD
$3.04M 0.05%
17,672
+6,629
+60% +$1.17M
KDP icon
380
Keurig Dr Pepper
KDP
$41B
$3.01M 0.05%
25,391
-647
-2% -$71.7K
GWW icon
381
W.W. Grainger
GWW
$66B
$3M 0.05%
10,610
+3,186
+43% +$834K
NUE icon
382
Nucor
NUE
$56.4B
$2.99M 0.05%
48,929
+2,560
+6% +$170K
SPPI
383
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$2.98M 0.05%
185,000
+28,000
+18% +$555K
MYOK
384
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$2.98M 0.05%
61,000
-37,000
-38% -$1.92M
SBAC icon
385
SBA Communications
SBAC
$18.3B
$2.96M 0.05%
17,314
-474
-3% -$78.6K
KPTI icon
386
Karyopharm Therapeutics
KPTI
$161M
$2.95M 0.05%
14,667
-12,200
-45% -$2.43M
TMUS icon
387
T-Mobile US
TMUS
$190B
$2.94M 0.05%
48,177
KHC icon
388
Kraft Heinz
KHC
$31.1B
$2.94M 0.05%
47,140
+1,313
+3% +$94K
XEL icon
389
Xcel Energy
XEL
$50.4B
$2.93M 0.05%
64,517
-2,653
-4% -$118K
ENB icon
390
Enbridge
ENB
$121B
$2.93M 0.05%
93,099
+9,908
+12% +$347K
MDCO
391
DELISTED
Medicines Co
MDCO
$2.9M 0.05%
88,000
ZBRA icon
392
Zebra Technologies
ZBRA
$12.6B
$2.89M 0.05%
20,763
-2,173
-9% -$278K
AKAO
393
DELISTED
Achaogen Inc
AKAO
$2.88M 0.05%
222,555
+50,000
+29% +$567K
MTB icon
394
M&T Bank
MTB
$36B
$2.86M 0.05%
15,530
+1,002
+7% +$187K
WEX icon
395
WEX
WEX
$6.07B
$2.85M 0.05%
+18,197
New +$2.74M
BSX icon
396
Boston Scientific
BSX
$67.6B
$2.84M 0.05%
103,853
TU icon
397
Telus
TU
$16.2B
$2.82M 0.05%
160,574
+55,578
+53% +$1.01M
AABA
398
DELISTED
Altaba Inc
AABA
$2.81M 0.05%
38,000
-18,984
-33% -$1.43M
ANAB icon
399
AnaptysBio
ANAB
$1.59B
$2.81M 0.05%
27,000
-12,500
-32% -$1.41M
VMW
400
DELISTED
VMware, Inc
VMW
$2.78M 0.05%
+22,930
New +$2.89M

Similar funds

Candriam SCA's Q1 2018 Portfolio in Review

As of Q1 2018, Candriam SCA held 808 positions worth $5.86B, up 1.4% from $5.78B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Candriam SCA's Q1 2018 filing shows 59 new, 345 increased, 246 reduced and 48 closed positions. Its largest new stake was Ecopetrol: 700,000 shares worth $13.5M. The largest sale was Baidu, an estimated $28.5M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 23% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q1 2018 buy was Ecopetrol: 700,000 shares worth $13.5M.
  • Candriam SCA added most to Biogen in Q1 2018, an estimated $50M increase.
  • Candriam SCA's biggest Q1 2018 reduction was Baidu, cutting an estimated $28.5M.
  • Candriam SCA fully exited Sociedad Química y Minera de Chile in Q1 2018, selling an estimated $13.4M.
  • Candriam SCA's ten largest holdings make up 17% of its $5.86B portfolio in Q1 2018.
  • Candriam SCA opened 59 new positions and closed 48 in Q1 2018.
  • Candriam SCA's portfolio value rose 1.4% quarter-over-quarter to $5.86B.

Based on Candriam SCA's 13F filing for Q1 2018, filed 9 May 2018.